外科术后氟比洛芬酯相关急性肾损伤的影响因素研究

doi:10.20047/j.issn1673-7210.2023.15.29

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (714 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the influencing factors of Flurbiprofen Axetil (FA) related acute kidney injury (AKI) after surgery. Methods All surgical inpatients who used FA in Zhuzhou Central Hospital between January and December 2019 were retrospectively investigated. The clinical data, use time, dosage and treatment course of FA were collected. The creatinine value of baseline and within seven days after treatment and others were collected. Univariate and multivariate analyses were performed with logistic regression model to assess the risk factors of AKI. Results Among 859 patients who received postoperative FA analgesia, 94 patients developed AKI. The incidence rate of AKI in patients with different ages, severe anemia, hypoproteinemia, chronic kidney disease, liver cirrhosis, and combined use of diuretics, angiotensin Ⅱ receptor blockers (ARB), and angiotensin-converting enzyme inhibitor (ACEI) were compared, with statistical differences (P<0.05). The results of multi factor analysis showed that severe anemia (OR=23.094, 95%CI: 4.604 to 115.853), chronic kidney disease (OR=12.080, 95%CI: 5.505 to 26.509), liver cirrhosis (OR=4.113, 95%CI: 1.602 to 10.558), ARB (OR=6.076, 95%CI: 2.553 to 14.462), and ACEI (OR=5.985, 95%CI: 3.060 to 11.703) were independent risk factors for the occurrence of AKI in patients (P＜0.05). Age 19 to 45 years old (OR=0.359, 95%CI: 0.172 to 0.753) and > 45 to 65 years old (OR=0.330, 95%CI: 0.181 to 0.604) were independent protective factors for AKI (P＜0.05). Conclusion FA related AKI is common after surgery. Early identification of risk factors and proactive interventions to prevent and reduce the occurrence of AKI.

Key words： Flurbiprofen Axetil Acute kidney injury Drug-induced kidney damage Influencing factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YUAN Xiangmin1 XIAO Jian2 HUANG Li1

Cite this article:

YUAN Xiangmin1 XIAO Jian2 HUANG Li1. Study on the influencing factors of Flurbiprofen Axetil related acute kidney injury after surgery[J]. 中国医药导报, 2023, 20(15): 131-134,158.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.15.29 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I15/131

[1] 潘坤明，陈灿，江莹，等.中国人群药物致急性肾损伤的系统评价[J].中国药房，2021，32（9）：1110-1117.
[2] 谢院生.伤肾的两大原则是“用好药”和“用好药”[J].中国医药科学，2020，10（1）：4-8.
[3] 谢院生.中草药相关肾损害的影响因素与防治策略[J].药学进展，2020，44（10）：743-751.
[4] 王融溶，饶跃峰，俞振伟，等.围手术期非甾体抗炎药合理使用情况的多中心回顾性研究[J].中国药学杂志，2019， 54（13）：1104-1108.
[5] 黄丽，魏龙，李何美，等.58例氟比洛芬不良反应文献分析[J].中国药物警戒，2022，19（4）：436-440.
[6] Zhu Y，Xu P，Wang Q，et al. Diclofenac-acetaminophen com- bination induced acute kidney injury in postoperative pain relief [J]. J Pharm Pharm Sci，2018，21（1）：19-26.
[7] 郁胜强，汤晓静.围手术期急性肾损伤危险因素及防治[J].中国实用内科杂志，2016，36（6）：435-438.
[8] Xu N，Pang K，Qi S，et al. Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing radical mastectomy：a retrospective cohort analysis [J]. BMC Anesthesiol，2022，22（1）：155.
[9] 王谋江，程翩翩，王鹏，等.帕瑞昔布钠与氟比洛芬酯用于骨折术后镇痛效果的评估[J].安徽医药，2021，25（9）：1874-1877.
[10] 沈珠，曹国文，鲍君杰，等.氟比洛芬酯的超说明书及不合理用药分析[J].中国医院药学杂志，2016，36（10）：844-847.
[11] 张春元，苏圣贤，吴立新，等.氟比洛芬酯术后镇痛对老年患者肾脏功能的影响[J].中国临床研究，2010，23（8）：693-694.
[12] Wang D，Yang SK，Zhao MX，et al. Low dose of flurbiprofen axetil decrease the rate of acute kidney injury after operation：a retrospective clinical data analysis of 9915 cases [J]. BMC Nephrol，2020，21（1）：52.
[13] 卢涛，聂晟，汪永平，等.中国住院成人患者围手术期急性肾损伤的流行病学及临床特点[J].江苏医药，2019， 45（9）：920-925.
[14] 朱贺，任奥林，周康，等.老年患者全髋关节置换术后急性肾损伤的危险因素分析及预测模型建立[J].临床麻醉学杂志，2021，37（1）：50-54.
[15] 李嘉欣，曾敏，董佳，等.围手术期急性肾损伤的研究进展[J].国际麻醉学与复苏杂志，2018，39（12）：1180-1183.
[16] 邓小明，袁红斌.成年人非阿片类镇痛药围手术期应用专家共识[J].国际麻醉学与复苏杂志，2019，40（1）：1-6.
[17] 马晓冉，冯艺，张万达.氟比洛芬酯术后镇痛对高血压病人肾功能的影响[J].中国疼痛医学杂志，2019，25（8）：608-613.
[18] Abuelo JG. Normotensive ischemic acute renal failure [J]. N Engl J Med，2007，357（8）：797-805.
[19] Wang K，Luo J，Zheng L，et al. Preoperative flurbiprofen axetil administration for acute postoperative pain：a meta- analysis of randomized controlled trials [J]. J Anesth，2017， 31（6）：852-860.
[20] 上海市医学会麻醉科专科分会，上海市医学会普通外科专科分会.普通外科围手术期疼痛管理上海专家共识（2020版）[J].中国实用外科杂志，2021，41（1）：31-37.
[21] 霍婷婷，成丹丹，聂煌.大剂量氟比洛芬酯用于普外科术后疼痛的疗效和安全性的Meta分析[J].临床合理用药杂志，2022，15（7）：25-30.
[22] 艾珍，陈崴.急性肾损伤的全程管理[J].华西医学，2022， 37（7）：1070-1075.
[23] 潘勇泉，江永发，尚平.人工股骨头置换术后急性肾损伤的相关因素分析[J].中国骨与关节损伤杂志，2021， 36（6）：595-597.
[24] Xie H，Zhang H，Peng J，et al. Prospective prescription review system promotes safe use of analgesics，improves clinical outcomes，and saves medical costs in surgical patients：insights from Nanjing Drum Tower Hospital [J]. Adv Ther，2022，39（1）：441-454.
[25] 莫荣浩，李梅，麦洁俭，等.尿NGAL联合血清CysC预测肾损伤合并急性心力衰竭患者临床病情严重度的有效性[J].中国医药科学，2021，11（13）：203-205，225.
[26] 陶志华.重视急性肾损伤标志物临床规范化应用和评价[J].中华检验医学杂志，2022，45（7）：661-664.